| |
| Issue |
Title |
| |
| Vol 17, No 1 (2024) |
STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia |
Abstract
PDF (Rus)
|
|
A. V. Zhuravlev, O. I. Knysh |
| |
| Vol 17, No 1 (2024) |
Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov |
| |
| Vol 17, No 1 (2024) |
Chemoreactomic analysis of acyzole in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs |
Abstract
PDF (Rus)
|
|
P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, R. A. Murashko, A. V. Zelenskaya, L. O. Alukhanyan, O. V. Shelemekh |
| |
| Vol 17, No 1 (2024) |
Clinical and economic implications of using daratumubab with lenalidomide in the 1st and 2nd lines of therapy for multiple myeloma patients |
Abstract
PDF (Rus)
|
|
О. I. Ivakhnenko, V. V. Ryazhenov, N. A. Falaleeva |
| |
| Vol 17, No 1 (2024) |
Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
S. К. Zyryanov, I. N. Dyakov |
| |
| Vol 17, No 1 (2024) |
Changes in patient recruitment parameters and their derivatives under the influence of external factors – population size and density of residence in a certain area |
Abstract
PDF (Rus)
|
|
S. S. Milovanov |
| |
| Vol 17, No 1 (2024) |
Assessing the awareness of doctors of various specialties in the treatment of osteoporosis |
Abstract
PDF (Rus)
|
|
V. A. Alekseeva, A. V. Krikova, Т. Yu. Filatova, E. V. Dmitrieva, A. V. Ovsyankin, E. S. Kuzminova |
| |
| Online First |
Antitumor effects of vitamin B12 in vitro, in vivo, in silico |
Abstract
PDF (Rus)
|
|
O. A. Gromova, D. E. Frolova, I. Yu. Torshin, M. V. Filimonova, M. A. Sorokina, I. A. Reyer, O. A. Limanova, L. E. Fedotova, L. A. Maiorova |
| |
| Vol 17, No 3 (2024) |
Chemoproteomic analysis of the pharmacological properties of vitamin В12 derivatives |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova |
| |
| Vol 16, No 4 (2023) |
Socio-economic burden of respiratory syncytial viral infection of the lower respiratory tract in children aged from birth to 5 years in the Russian Federation: modeling results |
Abstract
PDF (Rus)
|
|
V. I. Ignatyeva, D. Yu. Ovsyannikov, A. E. Tsygankov, E. E. Yagnenkova, V. R. Amirova, M. M. Maryanyan, A. S. Mokrova |
| |
| Vol 16, No 4 (2023) |
Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova |
| |
| Vol 16, No 4 (2023) |
Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova |
| |
| Vol 16, No 4 (2023) |
Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, K. V. Orlova |
| |
| Vol 16, No 4 (2023) |
Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis |
Abstract
PDF (Rus)
|
|
A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva |
| |
| Vol 16, No 4 (2023) |
Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer |
Abstract
PDF (Rus)
|
|
E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko |
| |
| Vol 16, No 4 (2023) |
Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova |
| |
| Vol 16, No 4 (2023) |
Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development |
Abstract
PDF (Rus)
PDF (Eng)
|
|
V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan |
| |
| Vol 16, No 4 (2023) |
Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market |
Abstract
PDF (Rus)
|
|
I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova |
| |
| Vol 16, No 3 (2023) |
Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina |
| |
| Vol 16, No 3 (2023) |
Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, I. N. Dyakov |
| |
| Vol 16, No 3 (2023) |
The role of ferritin in liver disease assessment |
Abstract
PDF (Rus)
|
|
V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik |
| |
| Vol 16, No 3 (2023) |
An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis |
Abstract
PDF (Rus)
|
|
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova |
| |
| Vol 16, No 3 (2023) |
Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia |
Abstract
PDF (Rus)
|
|
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva |
| |
| Vol 16, No 3 (2023) |
Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation |
Abstract
PDF (Rus)
|
|
D. V. Fedyaev, F. S. Nikitin, T. N. Artamonova, S. A. Kovaleva, V. V. Omelyanovskiy |
| |
| Vol 16, No 3 (2023) |
Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia |
Abstract
PDF (Rus)
|
|
N. A. Avxentyev, Yu. V. Makarova |
| |
| Vol 16, No 3 (2023) |
Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region |
Abstract
PDF (Rus)
|
|
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin |
| |
| Vol 16, No 3 (2023) |
Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer |
Abstract
PDF (Rus)
|
|
I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova |
| |
| Vol 16, No 4 (2023) |
Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C |
Abstract
PDF (Rus)
|
|
I. A. Narkevich, E. A. Tsitlionok |
| |
| Vol 16, No 4 (2023) |
Comparative chemomicrobiomic analysis of bacteriocins |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova |
| |
| Vol 16, No 2 (2023) |
Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice |
Abstract
PDF (Rus)
|
|
M. S. Soboleva |
| |
| Vol 16, No 2 (2023) |
Methodological approach to the formation of the list of high-tech medical care types |
Abstract
PDF (Rus)
|
|
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy |
| |
| Vol 16, No 2 (2023) |
Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure |
Abstract
PDF (Rus)
|
|
O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov |
| |
| Vol 16, No 2 (2023) |
Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina |
| |
| Vol 16, No 2 (2023) |
Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities |
Abstract
PDF (Rus)
|
|
R. E. Kalinin, I. A. Suchkov, M. M. Uporov, D. S. Titov, M. Yu. Klishchenko |
| |
| Vol 16, No 2 (2023) |
Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination |
Abstract
PDF (Rus)
|
|
I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova |
| |
| Vol 16, No 2 (2023) |
Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow |
Abstract
PDF (Rus)
|
|
E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova |
| |
| Vol 16, No 2 (2023) |
Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance |
Abstract
PDF (Rus)
|
|
N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova |
| |
| Vol 16, No 2 (2023) |
Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients |
Abstract
PDF (Rus)
|
|
E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov |
| |
| Vol 16, No 2 (2023) |
Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova |
| |
| Vol 16, No 2 (2023) |
Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic |
Abstract
PDF (Rus)
|
|
Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham |
| |
| Vol 16, No 1 (2023) |
Clinical approbation today: analysis of current problems and solutions |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, D. V. Lukyantseva, T. I. Alekseeva, Yu. V. Voropaeva, T. A. Tomilina, R. A. Teryan, A. O. Gadzhieva |
| |
| Vol 16, No 1 (2023) |
Principles of medical care standards development based on clinical guidelines |
Abstract
PDF (Rus)
|
|
Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy |
| |
| Vol 16, No 1 (2023) |
Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program |
Abstract
PDF (Rus)
|
|
T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina |
| |
| Vol 16, No 1 (2023) |
Efficiency of Levilimab in patients with moderate and severe COVID-19 |
Abstract
PDF (Rus)
|
|
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov |
| |
| Vol 16, No 1 (2023) |
Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022 |
Abstract
PDF (Rus)
|
|
D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin |
| |
| Vol 16, No 1 (2023) |
Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova |
| |
| Vol 15, No 4 (2022) |
Unified system and classification of indicators for integral assessment of the performance and effectiveness of medical care organization at the regional level in the Russian Federation |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, I. А. Mikhailov, D. V. Lukyantseva, Е. S. Samsonova, G. G. Lebedenko |
| |
| Vol 15, No 4 (2022) |
Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation |
Abstract
PDF (Rus)
|
|
I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova |
| |
| Vol 15, No 4 (2022) |
Antibiotic resistance of uropathogens in patients with nephrolithiasis and concomitant coronary heart disease |
Abstract
PDF (Rus)
|
|
R. V. Royuk, S. K. Yarovoy, I. B. Shikina |
| |
| Vol 15, No 4 (2022) |
Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention |
Abstract
PDF (Rus)
|
|
V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova |
| |
| 51 - 100 of 179 Items |
<< < 1 2 3 4 > >>
|
